Solventum purification and filtration portfolio expected to be highly complementary with Thermo Fisher’s bioproduction ...
Shares of Solventum Corp. shed 4.42% to $79.75 Friday, on what proved to be an all-around positive trading session for the ...
The addition of Solventum’s business provides a strategic fit with Thermo Fisher and will create value for customers, according to Marc N. Casper, chairman, president, and CEO of Thermo Fisher.
Solventum surpassed fourth-quarter revenue and earnings expectations while facing challenges in segments and regulatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback